From: Expression patterns of microRNAs associated with CML phases and their disease related targets
GO category | Count | % * | P-value |
---|---|---|---|
Biological process | |||
Regulation of transcription | 407 | 22.0 | 4.28E-20 |
Intracellular signaling cascade | 208 | 11.24 | 5.52E-12 |
Protein amino acid phosphorylation | 127 | 6.86 | 2.03E-11 |
Regulation of RNA metabolic process | 269 | 14.54 | 5.67E-10 |
Negative regulation of cellular biosynthetic process | 107 | 5.78 | 8.68E-10 |
Phosphate metabolic process | 159 | 8.59 | 7.5E-9 |
Regulation of small GTPase mediated signal transduction | 58 | 3.14 | 1.41E-8 |
Regulation of Ras protein signal transduction | 51 | 2.8 | 1.89E-8 |
Regulation of apoptosis | 132 | 7.1 | 1.35E-7 |
Vesicle-mediated transport | 101 | 5.5 | 2.2E-7 |
Negative regulation of signal transduction | 50 | 2.7 | 2.77E-7 |
Protein transport | 124 | 6.7 | 5.48E-7 |
Transmembrane receptor protein tyrosine kinase signaling pathway | 49 | 2.65 | 1.04E-6 |
Regulation of cell migration | 40 | 2.16 | 1.57E-6 |
Positive regulation of cell differentiation | 49 | 2.65 | 2.03E-6 |
Intracellular transport | 108 | 5.84 | 2.04E-6 |
Regulation of cell proliferation | 124 | 6.7 | 2.99E-6 |
Hematopoietic or lymphoid organ development | 52 | 2.8 | 7.41E-6 |
Regulation of protein kinase cascade | 47 | 2.5 | 9.5E-5 |
Regulation of protein kinase activity | 60 | 3.24 | 1.05E-4 |
Regulation of erythrocyte differentiation | 9 | 0.5 | 2.41E-4 |
Regulation of myeloid cell differentiation | 19 | 1.2 | 2.42E-4 |
Molecular function | |||
Transcription regulator activity | 268 | 14.5 | 8.81E-19 |
GTPase regulator activity | 82 | 4.4 | 1.32E-8 |
Protein kinase activity | 110 | 5.95 | 2.33E-8 |
Cytoskeletal protein binding | 90 | 4.86 | 1.06E-6 |
Transcription repressor activity | 63 | 3.41 | 1.46E-6 |
Protein domain specific binding | 65 | 3.51 | 1.67E-6 |
DNA binding | 314 | 16.97 | 2.51E-6 |
Zinc ion binding | 303 | 16.38 | 3.7E-5 |
Chromatin binding | 34 | 1.84 | 4.03E-5 |
Cation binding | 509 | 27.51 | 1.28E-4 |
SH3 domain binding | 24 | 1.3 | 1.51E-4 |
Pathway | |||
Endocytosis | 45 | 2.43 | 1.93E-8 |
Pathways in cancer | 64 | 3.46 | 1.41E-7 |
mTOR signaling pathway | 16 | 0.86 | 1.13E-4 |
Hedgehog signaling pathway | 16 | 0.86 | 2.82E-4 |
Chronic myeloid leukemia | 19 | 1.03 | 3.21E-4 |
Focal adhesion | 37 | 2.0 | 3.39E-4 |
Wnt signaling pathway | 29 | 1.57 | 8.77E-4 |